トライアドジャパン News Releases

Triad Japan Co., Ltd. to Establish New Pharmaceutical Development Division Office in Nihombashi-Kayabacho, Tokyo, in Line with Business Expansion

Triad Japan Co., Ltd. (Tokyo Office: Shibuya-ku, Tokyo; Representative Director: Mihoko Goto; herein… · 2026-06-16

[Held on April 25] Addressing anxieties and questions about schizophrenia treatment: 'An online seminar to think about schizophrenia treatment and its options together with families and patients'

Triad Japan to host an online seminar on schizophrenia treatment and clinical trials. · 2026-03-29

[Held on April 25] Addressing anxieties and questions about schizophrenia treatment: 'An online seminar to think about schizophrenia treatment and its options together with families and patients'

Triad Japan to host an online seminar on schizophrenia treatment and clinical trials. · 2026-03-28

Triad Japan Releases Report on Schizophrenia Online Seminar for International Clinical Trials Day

On International Clinical Trials Day, Triad Japan released a report on its successful online seminar… · 2026-05-20

Triad Japan Co., Ltd. Certified as "Health Management Excellent Corporation 2026 (Small and Medium-sized Enterprise Division)" for the Second Consecutive Year

Triad Japan Co., Ltd. has been certified as a "Health Management Excellent Corporation 2026 (Small a… · 2026-04-14

Triad Japan Co., Ltd. Certified as "Health Management Excellent Corporation 2026 (Small and Medium-sized Enterprise Division)" for the Second Consecutive Year

Triad Japan Co., Ltd. has been certified as a "Health Management Excellent Corporation 2026 (Small a… · 2026-04-14

Triad Japan Co., Ltd. Certified as "Health Management Excellent Corporation 2026 (Small and Medium-sized Enterprise Division)" for the Second Consecutive Year

Triad Japan Co., Ltd. has been certified as a "Health Management Excellent Corporation 2026 (Small a… · 2026-04-14